Daratumumab for newly diagnosed multiple myeloma: Pooled analysis of patients aged ≥65 years from GRIFFIN and PERSEUS.
      Google Scholar   
Citation:
Clin Lymphoma Myeloma Leuk vol 25 (10) 746-758.e6
Year:
2025
Type:
Manuscript
Funding:
AFT
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
15
Parents:
4415  
Children:
None
Program:
OGC
Primary Committee:
Myeloma
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                                                   
Networks:
LAPS-AL002, LAPS-MA036, LAPS-NY016, LAPS-UT003, NC002, OH008, OR013   
Study
AFT-29 (GRIFFIN)
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: